<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35312356</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS.</ArticleTitle><Pagination><StartPage>e2107391119</StartPage><MedlinePgn>e2107391119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2107391119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2107391119</ELocationID><Abstract><AbstractText>Connexin 43 (Cx43) gap junctions and hemichannels mediate astrocyte intercellular communication in the central nervous system under normal conditions and contribute to astrocyte-mediated neurotoxicity in amyotrophic lateral sclerosis (ALS). Here, we show that astrocyte-specific knockout of Cx43 in a mouse model of ALS slows disease progression both spatially and temporally, provides motor neuron (MN) protection, and improves survival. In addition, Cx43 expression is up-regulated in human postmortem tissue and cerebrospinal fluid from ALS patients. Using human induced pluripotent stem cell&#x2013;derived astrocytes (hiPSC-A) from both familial and sporadic ALS, we establish that Cx43 is up-regulated and that Cx43-hemichannels are enriched at the astrocyte membrane. We also demonstrate that the pharmacological blockade of Cx43-hemichannels in ALS astrocytes using GAP 19, a mimetic peptide blocker, and tonabersat, a clinically tested small molecule, provides neuroprotection of hiPSC-MN and reduces ALS astrocyte-mediated neuronal hyperexcitability. Extending the in vitro application of tonabersat with chronic administration to SOD1G93A mice results in MN protection with a reduction in reactive astrocytosis and microgliosis. Taking these data together, our studies identify Cx43 hemichannels as conduits of astrocyte-mediated disease progression and a pharmacological target for disease-modifying ALS therapies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almad</LastName><ForeName>Akshata A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0001-6603-2564</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taga</LastName><ForeName>Arens</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7059-3604</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Sarah K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-5883-0512</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welsh</LastName><ForeName>Connor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patankar</LastName><ForeName>Aneesh</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3003-3930</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-2890-2316</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rust</LastName><ForeName>Khalil</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0039-7752</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pokharel</LastName><ForeName>Aayush</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5517-4401</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plott</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5713-6062</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lillo</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2823-6619</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology, &amp; Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ 07101.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dastgheyb</LastName><ForeName>Raha</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4992-711X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haughey</LastName><ForeName>Norman</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5194-4122</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Jorge E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-9203-1602</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology, &amp; Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ 07101.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maragakis</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-7311-9614</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM099490</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS117604</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018031">Connexin 43</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C500216">GJA1 protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018031" MajorTopicYN="N">Connexin 43</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">astrocyte</Keyword><Keyword MajorTopicYN="N">connexin</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword></KeywordList><CoiStatement>The authors declare a competing interest. K.E. is a founder of and consultant for Q-state Biosciences, Quralis, and Enclear therapies. N.J.M. has filed US Patent Application #16868764 titled &#x201c;Neuroprotective Compounds for ALS.&#x201d;</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>21</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35312356</ArticleId><ArticleId IdType="pmc">PMC9060483</ArticleId><ArticleId IdType="doi">10.1073/pnas.2107391119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Konietzko U., M&#xfc;ller C. M., Astrocytic dye coupling in rat hippocampus: Topography, developmental onset, and modulation by protein kinase C. Hippocampus 4, 297&#x2013;306 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7842053</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabernero A., Giaume C., Medina J. M., Endothelin-1 regulates glucose utilization in cultured astrocytes by controlling intercellular communication through gap junctions. Glia 16, 187&#x2013;195 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8833189</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg G. S., Lampe P. D., Nicholson B. J., Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat. Cell Biol. 1, 457&#x2013;459 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10559992</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y., Dahl G., Function of the voltage gate of gap junction channels: Selective exclusion of molecules. Proc. Natl. Acad. Sci. U.S.A. 99, 697&#x2013;702 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC117368</ArticleId><ArticleId IdType="pubmed">11805325</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ G. J., Moreno A. P., Melman A., Spray D. C., Gap junction-mediated intercellular diffusion of Ca2+ in cultured human corporal smooth muscle cells. Am. J. Physiol. 263, C373&#x2013;C383 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1325115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence T. S., Beers W. H., Gilula N. B., Transmission of hormonal stimulation by cell-to-cell communication. Nature 272, 501&#x2013;506 (1978).</Citation><ArticleIdList><ArticleId IdType="pubmed">211417</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;ez J. C., Connor J. A., Spray D. C., Bennett M. V., Hepatocyte gap junctions are permeable to the second messenger, inositol 1,4,5-trisphosphate, and to calcium ions. Proc. Natl. Acad. Sci. U.S.A. 86, 2708&#x2013;2712 (1989).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC286987</ArticleId><ArticleId IdType="pubmed">2784857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong L., Zhu Y., Liang R., Zhao H. B., Gap junction mediated miRNA intercellular transfer and gene regulation: A novel mechanism for intercellular genetic communication. Sci. Rep. 6, 19884 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728487</ArticleId><ArticleId IdType="pubmed">26814383</ArticleId></ArticleIdList></Reference><Reference><Citation>Musil L. S., Goodenough D. A., Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 74, 1065&#x2013;1077 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">7691412</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana J. A., et al. , Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid. Redox Signal. 11, 369&#x2013;399 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713807</ArticleId><ArticleId IdType="pubmed">18816186</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L., Yang T., Cui S., Chen G., Connexin hemichannels in astrocytes: Role in CNS disorders. Front. Mol. Neurosci. 12, 23 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372977</ArticleId><ArticleId IdType="pubmed">30787868</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana J. A., Physiological functions of glial cell hemichannels. Adv. Exp. Med. Biol. 949, 93&#x2013;108 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27714686</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermietzel R., Hertberg E. L., Kessler J. A., Spray D. C., Gap junctions between cultured astrocytes: Immunocytochemical, molecular, and electrophysiological analysis. J. Neurosci. 11, 1421&#x2013;1432 (1991).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6575331</ArticleId><ArticleId IdType="pubmed">1851221</ArticleId></ArticleIdList></Reference><Reference><Citation>Rash J. E., Yasumura T., Dudek F. E., Nagy J. I., Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J. Neurosci. 21, 1983&#x2013;2000 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1804287</ArticleId><ArticleId IdType="pubmed">11245683</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouach N., et al. , Gap junctions and connexin expression in the normal and pathological central nervous system. Biol. Cell 94, 457&#x2013;475 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12566220</ArticleId></ArticleIdList></Reference><Reference><Citation>Giaume C., Theis M., Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system. Brain Res. Brain Res. Rev. 63, 160&#x2013;176 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19963007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallraff A., et al. , The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J. Neurosci. 26, 5438&#x2013;5447 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675300</ArticleId><ArticleId IdType="pubmed">16707796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouach N., Koulakoff A., Abudara V., Willecke K., Giaume C., Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322, 1551&#x2013;1555 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19056987</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan S. J., MacVicar B. A., Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431, 195&#x2013;199 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15356633</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A. M., et al. , Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113&#x2013;117 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., et al. , Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251&#x2013;253 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadeas S. T., Kraig S. E., O&#x2019;Banion C., Lepore A. C., Maragakis N. J., Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in&#xa0;vivo. Proc. Natl. Acad. Sci. U.S.A. 108, 17803&#x2013;17808 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203804</ArticleId><ArticleId IdType="pubmed">21969586</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., et al. , Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615&#x2013;622 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., et al. , Sporadic ALS astrocytes induce neuronal degeneration in&#xa0;vivo. Stem Cell Reports 8, 843&#x2013;855 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D. B., et al. , Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81, 1001&#x2013;1008 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A. M., et al. , Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824&#x2013;828 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., et al. , Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. U.S.A. 111, 829&#x2013;832 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S. A., et al. , Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A. A., et al. , Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia 64, 1154&#x2013;1169 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun S. P., et al. , Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson&#x2019;s disease. Nat. Med. 24, 931&#x2013;938 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6039259</ArticleId><ArticleId IdType="pubmed">29892066</ArticleId></ArticleIdList></Reference><Reference><Citation>Retamal M. A., Cort&#xe9;s C. J., Reuss L., Bennett M. V., S&#xe1;ez J. C., S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: Induction by oxidant stress and reversal by reducing agents. Proc. Natl. Acad. Sci. U.S.A. 103, 4475&#x2013;4480 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1450196</ArticleId><ArticleId IdType="pubmed">16537412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong M. L., Tan P. F., Holbrook J. D., Predicting functional decline and survival in amyotrophic lateral sclerosis. PLoS One 12, e0174925 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390993</ArticleId><ArticleId IdType="pubmed">28406915</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N., et al. , The PRO-ACT database: Design, initial analyses, and predictive features. Neurology 83, 1719&#x2013;1725 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4239834</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A., et al. , Role of human-induced pluripotent stem cell-derived spinal cord astrocytes in the functional maturation of motor neurons in a multielectrode array system. Stem Cells Transl. Med. 8, 1272&#x2013;1285 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6877769</ArticleId><ArticleId IdType="pubmed">31631575</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom W. J., et al. , Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes. Neurosci. Lett. 392, 52&#x2013;57 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16174551</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana J. A., et al. , ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 118, 826&#x2013;840 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108012</ArticleId><ArticleId IdType="pubmed">21294731</ArticleId></ArticleIdList></Reference><Reference><Citation>Abudara V., et al. , The connexin43 mimetic peptide Gap19 inhibits hemichannels without altering gap junctional communication in astrocytes. Front. Cell. Neurosci. 8, 306 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4204617</ArticleId><ArticleId IdType="pubmed">25374505</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., et al. , The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis. JAMA Neurol. 73, 425&#x2013;430 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26903389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., et al. , Absence of SOD1 gene abnormalities in familial amyotrophic lateral sclerosis with posterior column involvement without Lewy-body-like hyaline inclusions. Acta Neuropathol. 92, 528&#x2013;533 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8922067</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y. S., et al. , Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Exp. Mol. Med. 41, 140&#x2013;150 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2679239</ArticleId><ArticleId IdType="pubmed">19293633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., et al. , Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14, 781&#x2013;795 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., et al. , Tonabersat prevents inflammatory damage in the central nervous system by blocking connexin43 hemichannels. Neurotherapeutics 14, 1148&#x2013;1165 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722754</ArticleId><ArticleId IdType="pubmed">28560708</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., et al. , Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533, 493&#x2013;498 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5021195</ArticleId><ArticleId IdType="pubmed">27225120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaete P. S., Contreras J. E., A method for assessing ionic and molecular permeation in connexin hemichannels. Methods Enzymol. 654, 271&#x2013;293 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34120717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan W. N., et al. , Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)- 3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorg. Med. Chem. Lett. 9, 285&#x2013;290 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10021946</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdon H. J., et al. , Characterization of the binding of [3H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranes. Br. J. Pharmacol. 121, 1687&#x2013;1691 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564883</ArticleId><ArticleId IdType="pubmed">9283704</ArticleId></ArticleIdList></Reference><Reference><Citation>Tvedskov J. F., Iversen H. K., Olesen J., A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine. Cephalalgia 24, 875&#x2013;882 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15377319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley D. P., et al. , Diffusion-weighted MRI used to detect in&#xa0;vivo modulation of cortical spreading depression: Comparison of sumatriptan and tonabersat. Exp. Neurol. 172, 342&#x2013;353 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11716558</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton N., et al. , Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures. Br. J. Pharmacol. 121, 1679&#x2013;1686 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564882</ArticleId><ArticleId IdType="pubmed">9283703</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton N., Thompson M., Benzo[b]pyranols and related novel antiepileptic agents. Prog. Med. Chem. 37, 177&#x2013;200 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10845250</ArticleId></ArticleIdList></Reference><Reference><Citation>Rash J. E., et al. , Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun. Adhes. 8, 315&#x2013;320 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1805789</ArticleId><ArticleId IdType="pubmed">12064610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R., Zhang L., Wang M., Specific deletion connexin43 in astrocyte ameliorates cognitive dysfunction in APP/PS1 mice. Life Sci. 208, 175&#x2013;191 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30031059</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., et al. , Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer&#x2019;s disease. Cell Death Differ. 23, 1691&#x2013;1701 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5041199</ArticleId><ArticleId IdType="pubmed">27391799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., et al. , Inhibition of glial hemichannels by boldine treatment reduces neuronal suffering in a murine model of Alzheimer&#x2019;s disease. Glia 65, 1607&#x2013;1625 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28703353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu Z., Liu X., Fu Q., Gastrodin ameliorates Parkinson&#x2019;s disease by downregulating connexin 43. Mol. Med. Rep. 8, 585&#x2013;590 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23783886</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas-Andrade M., Naus C. C., Astrocytes in neuroprotection and neurodegeneration: The role of connexin43 and pannexin1. Neuroscience 323, 207&#x2013;221 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">25913636</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P., et al. , Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 108, 18126&#x2013;18131 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A. F., Gravel M., Kriz J., Treatment with minocycline after disease onset&#xa0;alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp. Neurol. 228, 69&#x2013;79 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21168408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., et al. , Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model. J. Neuroinflammation 11, 42 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4016493</ArticleId><ArticleId IdType="pubmed">24597481</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., et al. , Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci. 32, 3333&#x2013;3338 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3569730</ArticleId><ArticleId IdType="pubmed">22399755</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O., et al. , Astrocyte function is modified by Alzheimer&#x2019;s disease-like pathology in aged mice. J. Alzheimers Dis. 18, 177&#x2013;189 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19584439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy J. I., Li W., Hertzberg E. L., Marotta C. A., Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer&#x2019;s disease. Brain Res. 717, 173&#x2013;178 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8738268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., et al. , Epigenetic memory in induced pluripotent stem cells. Nature 467, 285&#x2013;290 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150836</ArticleId><ArticleId IdType="pubmed">20644535</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A., Maragakis N. J., A stocked toolbox for understanding the role of astrocytes in disease. Nat. Rev. Neurol. 14, 351&#x2013;362 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29769699</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;hondt C., et al. , Nutrient starvation decreases Cx43 levels and limits intercellular communication in primary bovine corneal endothelial cells. J. Membr. Biol. 249, 363&#x2013;373 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26873723</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyamada M., Takebe K., Oyamada Y., Regulation of connexin expression by transcription factors and epigenetic mechanisms. Biochim. Biophys. Acta 1828, 118&#x2013;133 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22244842</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Peng X., Li T., Liu L., Yang G., ERK and miRNA-1 target Cx43 expression and phosphorylation to modulate the vascular protective effect of angiotensin II. Life Sci. 216, 59&#x2013;66 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30419280</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M., et al. , Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol. Brain 10, 22 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F. P., Carrasco M. A., Siao M. C., Maniatis T., Eggan K., Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10, 608&#x2013;614 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S. P., et al. , Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain 142, 586&#x2013;605 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C. E., et al. , Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 19, 1739&#x2013;1749 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., et al. , Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50, 274&#x2013;289 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Zorec R., Astroglial signalling in health and disease. Neurosci. Lett. 689, 1&#x2013;4 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30031035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehre K. P., Levy L. M., Ottersen O. P., Storm-Mathisen J., Danbolt N. C., Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations. J. Neurosci. 15, 1835&#x2013;1853 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578153</ArticleId><ArticleId IdType="pubmed">7891138</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Catalan N. A., Doe C. Q., Ackerman S. D., The role of astrocyte-mediated plasticity in neural circuit development and function. Neural Dev. 16, 1 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789420</ArticleId><ArticleId IdType="pubmed">33413602</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;&#xf6;v C., Hillered L., Ebendal T., Erlandsson A., Engulfing astrocytes protect neurons from contact-induced apoptosis following injury. PLoS One 7, e33090 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312890</ArticleId><ArticleId IdType="pubmed">22461890</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., et al. , Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat. Med. 22, 397&#x2013;403 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B. M., Gordon J. W., Ripps M. E., Morrison J. H., Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: Neurochemical correlates of selective vulnerability. J. Comp. Neurol. 373, 619&#x2013;631 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8889947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H., et al. , TDP-43 accelerates age-dependent degeneration of interneurons. Sci. Rep. 7, 14972 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5668320</ArticleId><ArticleId IdType="pubmed">29097807</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossaini M., et al. , Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. J. Neuropathol. Exp. Neurol. 70, 662&#x2013;677 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21760539</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard J. P., Maragakis N. J., Induced pluripotent stem cells from ALS patients for disease modeling. Brain Res. 1607, 15&#x2013;25 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362997</ArticleId><ArticleId IdType="pubmed">25223906</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham P. L., Garrett F. G., Neurological mechanisms of migraine: Potential of the gap-junction modulator tonabersat in prevention of migraine. Cephalalgia 29 (suppl. 2), 1&#x2013;6 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3142555</ArticleId><ArticleId IdType="pubmed">19723120</ArticleId></ArticleIdList></Reference><Reference><Citation>Damodaram S., Thalakoti S., Freeman S. E., Garrett F. G., Durham P. L., Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache 49, 5&#x2013;20 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3138142</ArticleId><ArticleId IdType="pubmed">19125874</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrouilhe D., Dejean C., Mesnil M., Involvement of gap junction channels in the pathophysiology of migraine with aura. Front. Physiol. 5, 78 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3933780</ArticleId><ArticleId IdType="pubmed">24611055</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauge A. W., Asghar M. S., Schytz H. W., Christensen K., Olesen J., Effects of tonabersat on migraine with aura: A randomised, double-blind, placebo-controlled crossover study. Lancet Neurol. 8, 718&#x2013;723 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19570717</ArticleId></ArticleIdList></Reference><Reference><Citation>Goadsby P. J., Ferrari M. D., Csanyi A., Olesen J., Mills J. G.; Tonabersat TON-01-05 Study Group, Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia 29, 742&#x2013;750 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19222510</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialer M., et al. , Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res. 103, 2&#x2013;30 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Roybon L., et al. , Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep. 4, 1035&#x2013;1048 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229657</ArticleId><ArticleId IdType="pubmed">23994478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>